Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
NCT02378441
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Atorvastatin 20mg and Metformin SR 750mg
DRUG:
CJ-30056 20/750mg
Sponsor
HK inno.N Corporation